TW590746B - Method and food product for increasing muscle protein and reducing fat in animals - Google Patents

Method and food product for increasing muscle protein and reducing fat in animals Download PDF

Info

Publication number: TW590746B
Authority: TW; Taiwan
Prior art keywords: animal; composition; gastrointestinal; antibody; item
Prior art date: 1997-08-21

Application number

TW087113303A

Other languages

English (en)

Chinese (zh)

Inventor

Orn Adalsteinsson

Sandra Fitzpatrick-Mcelligott

Jeffrey G Hunchar

Original Assignee

Dcv Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-21

Filing date

1998-08-13

Publication date

2004-06-11

1998-08-13 Application filed by Dcv Inc filed Critical Dcv Inc

2004-06-11 Application granted granted Critical

2004-06-11 Publication of TW590746B publication Critical patent/TW590746B/zh

Links

241001465754 Metazoa Species 0.000 title claims abstract description 104
235000013305 food Nutrition 0.000 title claims abstract description 25
102000008934 Muscle Proteins Human genes 0.000 title claims abstract description 17
108010074084 Muscle Proteins Proteins 0.000 title claims abstract description 17
238000000034 method Methods 0.000 title abstract description 38
230000001965 increasing effect Effects 0.000 title abstract description 11
230000002496 gastric effect Effects 0.000 claims abstract description 45
239000000203 mixture Substances 0.000 claims abstract description 31
239000002858 neurotransmitter agent Substances 0.000 claims abstract description 30
235000013601 eggs Nutrition 0.000 claims description 51
101800001982 Cholecystokinin Proteins 0.000 claims description 48
IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 claims description 48
102100025841 Cholecystokinin Human genes 0.000 claims description 36
229940107137 cholecystokinin Drugs 0.000 claims description 36
108090000765 processed proteins & peptides Proteins 0.000 claims description 28
235000013336 milk Nutrition 0.000 claims description 26
210000004080 milk Anatomy 0.000 claims description 26
239000008267 milk Substances 0.000 claims description 26
238000012360 testing method Methods 0.000 claims description 18
229940088597 hormone Drugs 0.000 claims description 16
239000005556 hormone Substances 0.000 claims description 16
229960005486 vaccine Drugs 0.000 claims description 16
238000004519 manufacturing process Methods 0.000 claims description 14
108010051696 Growth Hormone Proteins 0.000 claims description 8
102000018997 Growth Hormone Human genes 0.000 claims description 8
230000008602 contraction Effects 0.000 claims description 8
239000000122 growth hormone Substances 0.000 claims description 8
-1 urcotin Proteins 0.000 claims description 8
230000002401 inhibitory effect Effects 0.000 claims description 7
230000000968 intestinal effect Effects 0.000 claims description 7
102000004196 processed proteins & peptides Human genes 0.000 claims description 7
239000000126 substance Substances 0.000 claims description 6
239000003814 drug Substances 0.000 claims description 5
210000000232 gallbladder Anatomy 0.000 claims description 5
LVRVABPNVHYXRT-BQWXUCBYSA-N 52906-92-0 Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C1=CC=CC=C1 LVRVABPNVHYXRT-BQWXUCBYSA-N 0.000 claims description 4
102000002419 Motilin Human genes 0.000 claims description 4
101800002372 Motilin Proteins 0.000 claims description 4
108090000189 Neuropeptides Proteins 0.000 claims description 4
229940079593 drug Drugs 0.000 claims description 4
230000002068 genetic effect Effects 0.000 claims description 4
210000005036 nerve Anatomy 0.000 claims description 4
239000003488 releasing hormone Substances 0.000 claims description 4
210000002966 serum Anatomy 0.000 claims description 4
235000019737 Animal fat Nutrition 0.000 claims description 3
210000004369 blood Anatomy 0.000 claims description 3
239000008280 blood Substances 0.000 claims description 3
235000021277 colostrum Nutrition 0.000 claims description 3
210000003022 colostrum Anatomy 0.000 claims description 3
210000004211 gastric acid Anatomy 0.000 claims description 3
210000000936 intestine Anatomy 0.000 claims description 3
230000004936 stimulating effect Effects 0.000 claims description 3
150000001412 amines Chemical class 0.000 claims description 2
235000013365 dairy product Nutrition 0.000 claims description 2
239000003112 inhibitor Substances 0.000 claims description 2
230000001737 promoting effect Effects 0.000 claims description 2
102000003797 Neuropeptides Human genes 0.000 claims 3
239000000859 incretin Substances 0.000 claims 3
MGXWVYUBJRZYPE-YUGYIWNOSA-N incretin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=C(O)C=C1 MGXWVYUBJRZYPE-YUGYIWNOSA-N 0.000 claims 3
CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 claims 3
102000013585 Bombesin Human genes 0.000 claims 2
108010051479 Bombesin Proteins 0.000 claims 2
108010022152 Corticotropin-Releasing Hormone Proteins 0.000 claims 2
102000012289 Corticotropin-Releasing Hormone Human genes 0.000 claims 2
239000000055 Corticotropin-Releasing Hormone Substances 0.000 claims 2
URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 claims 2
108010003205 Vasoactive Intestinal Peptide Proteins 0.000 claims 2
102400000015 Vasoactive intestinal peptide Human genes 0.000 claims 2
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 claims 2
229960004373 acetylcholine Drugs 0.000 claims 2
230000000890 antigenic effect Effects 0.000 claims 2
DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 claims 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims 2
102400000739 Corticotropin Human genes 0.000 claims 1
101800000414 Corticotropin Proteins 0.000 claims 1
QEEBRPGZBVVINN-UHFFFAOYSA-N Desacetyl-bufotalin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C1(O)CCC2C=1C=CC(=O)OC=1 QEEBRPGZBVVINN-UHFFFAOYSA-N 0.000 claims 1
101000632994 Homo sapiens Somatostatin Proteins 0.000 claims 1
102100029563 Somatostatin Human genes 0.000 claims 1
210000000941 bile Anatomy 0.000 claims 1
QEEBRPGZBVVINN-BMPKRDENSA-N bufalin Chemical compound C=1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@H]5CC4)C)CC[C@@]32C)C=CC(=O)OC=1 QEEBRPGZBVVINN-BMPKRDENSA-N 0.000 claims 1
108010057108 condensin complexes Proteins 0.000 claims 1
IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 claims 1
229960000258 corticotropin Drugs 0.000 claims 1
239000000049 pigment Substances 0.000 claims 1
229920001184 polypeptide Polymers 0.000 claims 1
229960000553 somatostatin Drugs 0.000 claims 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 claims 1
230000002227 vasoactive effect Effects 0.000 claims 1
239000003925 fat Substances 0.000 description 34
235000019197 fats Nutrition 0.000 description 33
210000002969 egg yolk Anatomy 0.000 description 26
235000013345 egg yolk Nutrition 0.000 description 21
241000287828 Gallus gallus Species 0.000 description 19
235000013330 chicken meat Nutrition 0.000 description 18
108010000912 Egg Proteins Proteins 0.000 description 17
102000002322 Egg Proteins Human genes 0.000 description 17
210000003205 muscle Anatomy 0.000 description 17
230000000694 effects Effects 0.000 description 16
239000000427 antigen Substances 0.000 description 14
102000036639 antigens Human genes 0.000 description 14
108091007433 antigens Proteins 0.000 description 14
238000010609 cell counting kit-8 assay Methods 0.000 description 12
230000028993 immune response Effects 0.000 description 12
102000004169 proteins and genes Human genes 0.000 description 12
108090000623 proteins and genes Proteins 0.000 description 12
102000005962 receptors Human genes 0.000 description 12
108020003175 receptors Proteins 0.000 description 12
244000144977 poultry Species 0.000 description 11
235000013594 poultry meat Nutrition 0.000 description 11
241000283690 Bos taurus Species 0.000 description 10
239000000843 powder Substances 0.000 description 10
239000000047 product Substances 0.000 description 10
238000002347 injection Methods 0.000 description 9
239000007924 injection Substances 0.000 description 9
108010087230 Sincalide Proteins 0.000 description 8
239000002671 adjuvant Substances 0.000 description 6
230000033001 locomotion Effects 0.000 description 6
230000008014 freezing Effects 0.000 description 5
238000007710 freezing Methods 0.000 description 5
238000002255 vaccination Methods 0.000 description 5
241000271566 Aves Species 0.000 description 4
108020004414 DNA Proteins 0.000 description 4
108060003951 Immunoglobulin Proteins 0.000 description 4
241000124008 Mammalia Species 0.000 description 4
239000000562 conjugate Substances 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
239000002552 dosage form Substances 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
210000001035 gastrointestinal tract Anatomy 0.000 description 4
102000018358 immunoglobulin Human genes 0.000 description 4
208000030175 lameness Diseases 0.000 description 4
235000013372 meat Nutrition 0.000 description 4
235000016709 nutrition Nutrition 0.000 description 4
238000011160 research Methods 0.000 description 4
102000014914 Carrier Proteins Human genes 0.000 description 3
108010078791 Carrier Proteins Proteins 0.000 description 3
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
241001494479 Pecora Species 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
239000002253 acid Substances 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
235000019789 appetite Nutrition 0.000 description 3
230000036528 appetite Effects 0.000 description 3
201000010099 disease Diseases 0.000 description 3
230000037406 food intake Effects 0.000 description 3
239000012634 fragment Substances 0.000 description 3
210000005095 gastrointestinal system Anatomy 0.000 description 3
230000000521 hyperimmunizing effect Effects 0.000 description 3
230000003053 immunization Effects 0.000 description 3
230000016784 immunoglobulin production Effects 0.000 description 3
229940072221 immunoglobulins Drugs 0.000 description 3
231100000252 nontoxic Toxicity 0.000 description 3
230000003000 nontoxic effect Effects 0.000 description 3
239000002245 particle Substances 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
230000001766 physiological effect Effects 0.000 description 3
239000006187 pill Substances 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000007921 spray Substances 0.000 description 3
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 3
QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
241001260012 Bursa Species 0.000 description 2
241000938605 Crocodylia Species 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
241000282412 Homo Species 0.000 description 2
101710151321 Melanostatin Proteins 0.000 description 2
102400000064 Neuropeptide Y Human genes 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
102000007562 Serum Albumin Human genes 0.000 description 2
108010071390 Serum Albumin Proteins 0.000 description 2
241000282887 Suidae Species 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000000481 breast Anatomy 0.000 description 2
235000019577 caloric intake Nutrition 0.000 description 2
239000002775 capsule Substances 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
230000008859 change Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000037213 diet Effects 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
235000014103 egg white Nutrition 0.000 description 2
210000000969 egg white Anatomy 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
230000002124 endocrine Effects 0.000 description 2
235000012631 food intake Nutrition 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
235000011389 fruit/vegetable juice Nutrition 0.000 description 2
108010074605 gamma-Globulins Proteins 0.000 description 2
239000003629 gastrointestinal hormone Substances 0.000 description 2
230000036541 health Effects 0.000 description 2
230000003054 hormonal effect Effects 0.000 description 2
230000036039 immunity Effects 0.000 description 2
238000002649 immunization Methods 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
208000028774 intestinal disease Diseases 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
244000005700 microbiome Species 0.000 description 2
238000006386 neutralization reaction Methods 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 2
238000010647 peptide synthesis reaction Methods 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
210000000329 smooth muscle myocyte Anatomy 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000013589 supplement Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
239000003826 tablet Substances 0.000 description 2
230000014616 translation Effects 0.000 description 2
210000000689 upper leg Anatomy 0.000 description 2
239000012646 vaccine adjuvant Substances 0.000 description 2
229940124931 vaccine adjuvant Drugs 0.000 description 2
CFQYOTZLYKJVKS-UHFFFAOYSA-N 4-[9-(4-carbamimidoylphenoxy)nonoxy]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCCCCOC1=CC=C(C(N)=N)C=C1 CFQYOTZLYKJVKS-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
206010001497 Agitation Diseases 0.000 description 1
235000021411 American diet Nutrition 0.000 description 1
235000002198 Annona diversifolia Nutrition 0.000 description 1
241000272517 Anseriformes Species 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
102000004859 Cholecystokinin Receptors Human genes 0.000 description 1
108090001085 Cholecystokinin Receptors Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
206010011224 Cough Diseases 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
208000030814 Eating disease Diseases 0.000 description 1
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
208000019454 Feeding and Eating disease Diseases 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
239000004181 Flavomycin Substances 0.000 description 1
208000018522 Gastrointestinal disease Diseases 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
241000282838 Lama Species 0.000 description 1
235000019687 Lamb Nutrition 0.000 description 1
208000002720 Malnutrition Diseases 0.000 description 1
108700021154 Metallothionein 3 Proteins 0.000 description 1
102100028708 Metallothionein-3 Human genes 0.000 description 1
235000005135 Micromeria juliana Nutrition 0.000 description 1
240000001899 Murraya exotica Species 0.000 description 1
SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical compound C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 1
108091061960 Naked DNA Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
241000286209 Phasianidae Species 0.000 description 1
241000288906 Primates Species 0.000 description 1
240000002114 Satureja hortensis Species 0.000 description 1
235000007315 Satureja hortensis Nutrition 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
102000002852 Vasopressins Human genes 0.000 description 1
108010004977 Vasopressins Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
210000000579 abdominal fat Anatomy 0.000 description 1
230000009471 action Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000003470 adrenal cortex hormone Substances 0.000 description 1
125000003172 aldehyde group Chemical group 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
230000007815 allergy Effects 0.000 description 1
OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
210000000436 anus Anatomy 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
229910052785 arsenic Inorganic materials 0.000 description 1
RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
PERZMHJGZKHNGU-JGYWJTCASA-N bambermycin Chemical compound O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@H](O1)C(=O)NC=1C(CCC=1O)=O)O)C)[C@H]1[C@@H](OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]1OC(N)=O PERZMHJGZKHNGU-JGYWJTCASA-N 0.000 description 1
230000006399 behavior Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
235000013361 beverage Nutrition 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
235000015895 biscuits Nutrition 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
230000037396 body weight Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
235000018823 dietary intake Nutrition 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
235000014632 disordered eating Nutrition 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
235000005686 eating Nutrition 0.000 description 1
230000020595 eating behavior Effects 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
210000003890 endocrine cell Anatomy 0.000 description 1
210000003372 endocrine gland Anatomy 0.000 description 1
210000000750 endocrine system Anatomy 0.000 description 1
210000000105 enteric nervous system Anatomy 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
238000000605 extraction Methods 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
235000019374 flavomycin Nutrition 0.000 description 1
235000012041 food component Nutrition 0.000 description 1
239000005417 food ingredient Substances 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
210000003736 gastrointestinal content Anatomy 0.000 description 1
230000007661 gastrointestinal function Effects 0.000 description 1
239000003626 gastrointestinal polypeptide Substances 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
235000006486 human diet Nutrition 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
229940027941 immunoglobulin g Drugs 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000003701 inert diluent Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
208000018937 joint inflammation Diseases 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000008101 lactose Substances 0.000 description 1
210000002414 leg Anatomy 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000002502 liposome Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
235000004213 low-fat Nutrition 0.000 description 1
230000001071 malnutrition Effects 0.000 description 1
235000000824 malnutrition Nutrition 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
235000012054 meals Nutrition 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
210000003739 neck Anatomy 0.000 description 1
230000017066 negative regulation of growth Effects 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
230000000926 neurological effect Effects 0.000 description 1
230000003227 neuromodulating effect Effects 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
208000015380 nutritional deficiency disease Diseases 0.000 description 1
235000008935 nutritious Nutrition 0.000 description 1
239000006186 oral dosage form Substances 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000002895 organic esters Chemical class 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
210000002976 pectoralis muscle Anatomy 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000000863 peptide conjugate Substances 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
210000002706 plastid Anatomy 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
235000015277 pork Nutrition 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
229910052704 radon Inorganic materials 0.000 description 1
SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
230000009467 reduction Effects 0.000 description 1
235000021067 refined food Nutrition 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
229910000679 solder Inorganic materials 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000001694 spray drying Methods 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000000021 stimulant Substances 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
229960003726 vasopressin Drugs 0.000 description 1
239000013598 vector Substances 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
230000009278 visceral effect Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
238000005303 weighing Methods 0.000 description 1
230000004580 weight loss Effects 0.000 description 1
238000003466 welding Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
210000004885 white matter Anatomy 0.000 description 1
235000014101 wine Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Polymers & Plastics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Zoology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Food Science & Technology (AREA)
Animal Husbandry (AREA)
Microbiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Fodder In General (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

TW087113303A 1997-08-21 1998-08-13 Method and food product for increasing muscle protein and reducing fat in animals TW590746B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/915,627 US6086878A (en)	1997-08-21	1997-08-21	Method of increasing muscle protein and reducing fat in animals

Publications (1)

Publication Number	Publication Date
TW590746B true TW590746B (en)	2004-06-11

Family

ID=25436028

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW087113303A TW590746B (en)	1997-08-21	1998-08-13	Method and food product for increasing muscle protein and reducing fat in animals

Country Status (12)

Country	Link
US (1)	US6086878A (fr)
EP (1)	EP1005371A2 (fr)
JP (1)	JP2001515050A (fr)
KR (1)	KR20010023082A (fr)
CN (1)	CN1275918A (fr)
AU (1)	AU746071B2 (fr)
CA (1)	CA2299291A1 (fr)
EG (1)	EG21936A (fr)
MY (1)	MY125875A (fr)
NZ (1)	NZ502849A (fr)
TW (1)	TW590746B (fr)
WO (1)	WO1999008708A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7238351B2 (en) *	1999-07-15	2007-07-03	Peter Nash	Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
US7241443B1 (en) *	1999-07-15	2007-07-10	Camas Incorporated	Immunogen adherence inhibitor and method of making and using same
US20030082647A1 (en) *	2000-12-12	2003-05-01	Reenan Robert A.	Transporter protein
EP1399553A2 (fr)	2000-12-12	2004-03-24	The University of Connecticut	Polynucleotides codant pour des transporteurs cellulaires et procedes de leur utilisation
US7244427B2 (en) *	2001-01-30	2007-07-17	The Lauridsen Group Incorporated	Isolated bovine IgG heavy chain protein and its use as an antimicrobial
WO2002078741A2 (fr) *	2001-01-30	2002-10-10	The Lauridsen Group, Incorporated	Procedes et compositions destines a moduler le systeme immunitaire des animaux
CA2437099A1 (fr) *	2001-01-30	2002-10-10	The Lauridsen Group, Incorporated	Procedes et compositions destines au traitement de dysfonctions immunitaires
US20030190314A1 (en) *	2001-01-30	2003-10-09	The Lauridsen Group	Methods and compositions of treatment for modulating the immune system of animals
US20030103962A1 (en) *	2001-10-09	2003-06-05	Campbell Joy M.	Methods and compositions for modulating the immune system of animals
US6939954B2 (en)	2001-01-30	2005-09-06	The Lauridsen Group Incorporated	Isolated bovine lgG heavy chain protein and its use as an antimicrobial
BR0207685A (pt)	2001-02-14	2006-01-17	Lauridsen Group Inc	Método para aumentar o peso vivo de aves domésticas, produto alimentìcio de plasma, e, produto aquoso de plasma
AU2002318137A1 (en) *	2001-05-18	2002-12-03	Arkion Life Sciences	Method of increasing uniformity in avians
GB2389362B (en) *	2002-06-05	2006-02-15	Walcom Animal Science	Antibodies to adipose tissues
US6729265B2 (en)	2002-06-27	2004-05-04	Arkion Life Sciences Llc	Supplemented antibody feed to enter the circulating system of newborns
US8519008B2 (en)	2003-01-22	2013-08-27	Purina Animal Nutrition Llc	Method and composition for improving the health of young monogastric mammals
US9701737B2 (en) *	2003-02-19	2017-07-11	Camas, Incorporated	Immunogen adherence and method of making and using same
JP2008517975A (ja)	2004-10-25	2008-05-29	サイトスバイオテクノロジーアーゲー	胃酸分泌抑制ポリペプチド（ｇｉｐ）抗原アッセイ及びその使用
CA2702577A1 (fr)	2007-10-15	2009-04-23	Jbs United, Inc.	Procede permettant d'accroitre la performance d'une progeniture
US8501220B2 (en)	2009-12-31	2013-08-06	R&D Lifesciences	Stabilized liquid egg material for extended shelf life
CA2798151A1 (fr)	2010-05-07	2011-11-10	Camas Incorporated	Inhibiteurs d'adherence d'immunogenes et procede de fabrication et d'utilisation de ceux-ci
US9089150B2 (en) *	2011-05-27	2015-07-28	National Cheng Kung University	Method for lowering feed conversion rate
CN102241761A (zh) *	2011-06-14	2011-11-16	中山大学	一种尼罗罗非鱼胆囊收缩素及其编码核酸和功能八肽的应用
CN106036185A (zh) *	2016-07-28	2016-10-26	四川昕泰科技有限公司	一种蛋鸡饲料添加剂
US10602757B2 (en) *	2016-12-15	2020-03-31	Bioforte Biotechnology(Shenzhen) Co., Ltd.	Nutrition supplement for animal and use thereof
CN109156386B (zh) *	2018-08-27	2021-02-12	中国水产科学研究院黄海水产研究所	一种调控红鳍东方鲀肌肉脂肪沉积的营养学方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4748018A (en) *	1984-02-07	1988-05-31	Stolle Research & Development Corp.	Method of passive immunization of mammals using avian antibody
US4599229A (en) *	1985-09-09	1986-07-08	International Minerals & Chemical Corp.	Method of promoting animal growth using antibodies against somatostatin
EP0225254B1 (fr) *	1985-11-25	1994-03-16	Ghen Corporation	Substance contenant un anticorps spécifique à partir d'oeufs, méthode de production et son utilisation
US4929600A (en) *	1988-03-18	1990-05-29	University Of Deleware	Endocrine manipulation to improve body composition of poultry
US5319073A (en) *	1992-02-07	1994-06-07	The United States Of America, As Represented By The Department Of Health & Human Services	Method of purifying cholecystokinin receptor protein
US5340834A (en) *	1993-01-05	1994-08-23	Stitt Paul A	Method of increasing muscle mass in chickens
US5367054A (en) *	1993-04-12	1994-11-22	Stolle Research & Development Corp.	Large-scale purification of egg immunoglobulin
US5814316A (en) *	1994-08-05	1998-09-29	Wisconsin Alumni Research Foundation	Compound to mimick a naturally occurring peptide's effect
CN1127352C (zh) *	1994-08-05	2003-11-12	威斯康星校友研究基金会	用于改善饲料效率的肠促胰酶肽抗体
US5739106A (en) *	1995-06-07	1998-04-14	Rink; Timothy J.	Appetite regulating compositions
US5725873A (en) *	1996-07-22	1998-03-10	Wisconsin Alumni Research Foundation	Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
US5772999A (en) *	1996-07-30	1998-06-30	Dcv Biologics, L.P.	Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals

1997
- 1997-08-21 US US08/915,627 patent/US6086878A/en not_active Expired - Fee Related
1998
- 1998-08-13 TW TW087113303A patent/TW590746B/zh not_active IP Right Cessation
- 1998-08-18 EP EP98942086A patent/EP1005371A2/fr not_active Withdrawn
- 1998-08-18 CA CA002299291A patent/CA2299291A1/fr not_active Abandoned
- 1998-08-18 WO PCT/US1998/017052 patent/WO1999008708A2/fr not_active Application Discontinuation
- 1998-08-18 CN CN98810183A patent/CN1275918A/zh active Pending
- 1998-08-18 KR KR1020007001701A patent/KR20010023082A/ko not_active Ceased
- 1998-08-18 JP JP2000509444A patent/JP2001515050A/ja active Pending
- 1998-08-18 AU AU90216/98A patent/AU746071B2/en not_active Ceased
- 1998-08-18 NZ NZ502849A patent/NZ502849A/en unknown
- 1998-08-20 EG EG96898A patent/EG21936A/xx active
- 1998-08-20 MY MYPI98003795A patent/MY125875A/en unknown

Also Published As

Publication number	Publication date
US6086878A (en)	2000-07-11
CN1275918A (zh)	2000-12-06
WO1999008708A3 (fr)	1999-04-15
WO1999008708A2 (fr)	1999-02-25
EG21936A (en)	2002-04-30
JP2001515050A (ja)	2001-09-18
NZ502849A (en)	2002-06-28
AU9021698A (en)	1999-03-08
KR20010023082A (ko)	2001-03-26
EP1005371A2 (fr)	2000-06-07
MY125875A (en)	2006-08-30
CA2299291A1 (fr)	1999-02-25
AU746071B2 (en)	2002-04-11

Publication	Publication Date	Title
TW590746B (en)	2004-06-11	Method and food product for increasing muscle protein and reducing fat in animals
EP1149590B1 (fr)	2006-08-30	Utilisation d'anticorps d'un peptide intestinal pour augmenter l'efficacité de l'alimentation
KR19990022555A (ko)	1999-03-25	인히빈 조성물 및 증식 성능 개선 방법
RU2723097C1 (ru)	2020-06-08	Способ получения яичного желтка с высоким содержанием af-16
AU614040B2 (en)	1991-08-15	Increased protein production in animals
US20020012666A1 (en)	2002-01-31	A method for increasing weight gain and feed efficiency
US20030017154A1 (en)	2003-01-23	Method of increasing uniformity in avians
MXPA00001742A (en)	2001-05-17	Method and food product for increasing muscle protein and reducing fat in animals
US6729265B2 (en)	2004-05-04	Supplemented antibody feed to enter the circulating system of newborns
EP1509547B1 (fr)	2008-10-29	Anticorps contre des corps adipeux
JPH03502572A (ja)	1991-06-13	動物又はヒトにおいて成長率及び／又は飼料又は食物の利用及び／又は抵抗性を増加させる製品及びその方法
MXPA97000878A (en)	1998-11-09	Cck antibodies employed to improve food efficiency
WO2013014269A1 (fr)	2013-01-31	Procédé pour la promotion de la croissance d'un animal nouveau-né
WO2004002529A1 (fr)	2004-01-08	Anticorps ajoutes dans l'appareil circulatoire de nouveau-nes

Legal Events

Date	Code	Title	Description
2007-07-21	MM4A	Annulment or lapse of patent due to non-payment of fees